Collaboration. Communication. Compliance.
Working with global health authorities and industry leaders to provide secure cloud technology that drives forward regulatory science and innovation.
Delivering the future of secure cloud computing and collaboration to drive regulatory science forward.
Existing regulatory data solutions are plagued by outdated technology,
poor interoperability, and limited tools for supporting sponsor–regulator collaboration, raising
compliance risks and causing time-to-results to be measured in months, not days.
DNAnexus offers the leading secure collaboration and cloud computing platform. With maintained
FedRAMP authorization and platform features such as chain of provenance tracking, data immutability and
high-performance data transfer, DNAnexus delivers an out-of-the-box,
regulatory-grade solution for collaboration in the cloud.
DNAnexus works with health authorities and the life sciences industry to enable collaborative regulatory science.
Grounded in our industry-leading Trusted Research Environment capabilities, we offer a cutting-edge cloud-based platform designed to unlock the power of collaborative data analysis. By offering a secure and scalable environment, DNAnexus enables health authorities to invite stakeholders from across the globe to compare, share, and validate regulatory information—such as submissions, genomics, EHR and real-world data, and more.
The Previous State:
Months to connect collaborators and partners
Months to ingest data
Security risks due to physical data transfer
Inability to install your own software
Limited ability to perform collaborative research
Reliant on siloed on-premise computing resources
High latency and limited bandwidth
DNAnexus Enables:
Connecting collaborators and partners in hours, not months
Customizable virtual workstations
Collaborative hub for data and applications
Self-serve data analysis in the cloud
Low latency and high bandwidth
Transformative user experience
DNAnexus and LORENZ Partner to Enable Collaborative Regulatory Submission Validation and Scientific Review in the Cloud via Trusted Regulatory Spaces:
Working together on the PRISM research collaboration between industry and the U.S. Food and Drug Administration (FDA) to demonstrate the feasibility of collaborative regulatory submission validation, Lorenz and DNAnexus deployed Lorenz' eValidator solution on precisionFDA, the FDA’s production cloud platform powered by DNAnexus for multi-omics and real-world data in regulatory submissions.
Ushering in the future of collaborative review of regulatory submissions with Trusted Regulatory Spaces.
The latest evolution of our Trusted Research Environment offering transforms the regulatory submission process by enabling seamless collaboration and communication between sponsors, global health authorities, third-party data providers, and standards development organizations, all within a secure cloud environment. This innovative feature set is designed to streamline the journey from discovery to regulatory approval, significantly speeding up the time-to-market for groundbreaking therapies and diagnostics.
Collaborative Analysis and Data Access
Create, manage, and share submission-ready datasets with unprecedented ease, ensuring that all parties have access to the critical data they need, when they need it.Security, Compliance and Data Preservation
Maintain a clear audit trail of all interactions and data exchanges with robust tracking, version control, and workspace archival, while also benefiting from industry-leading security and regulatory compliance.Trusted Regulatory Spaces
Engage with your data and collaborators through an intuitive interface and powerful analytics tools that allow for real-time feedback and interaction between sponsors and health authorities, facilitating a more efficient and effective regulatory submission process.Familiar Tools and Processes
Leverage familiar, industry standard tools that are deployed within the secure confines of our cloud platform. Minimize the need to rework processes and workflow steps for sponsors and reviewers.Working towards a future where global regulatory collaboration is possible.
Why work with DNAnexus?
- Production-Ready
- Secure and Compliant
- Transformation without Disruption
- Tested and Trusted
Production-Ready
Production-Ready
Not Just a Vision - A Reality
Our platform leverages in-production solutions that already meet the most stringent security, privacy and data residency requirements and have been adopted by leading global health authorities and life sciences organizations.
Secure and Compliant
Secure and Compliant
Meeting the Most Stringent Regulatory Requirements
We have achieved a FISMA Authorization to Operate, building on DNAnexus’ FedRAMP authorization and 21 CFR Part 11 Computer System Validation, and platform features, such as chain of provenance tracking and data immutability, to deliver a regulatory grade service for collaborative science in the cloud.
Transformation without Disruption
Transformation without Disruption
Offering a Smooth Transition to Cloud Collaboration
We enable established technology applications and validation tools to operate within our secure collaboration platform, ensuring that sponsors and reviewers don't have to change their existing processes and accelerating global adoption.
Tested and Trusted
Tested and Trusted
A Track Record of Demonstrated Success
Powered by DNAnexus, precisionFDA launched in 2015 to enable the advancement of regulatory science and has evolved into a trusted, FISMA-authorized platform for secure collaboration and cloud computing. Since inception, precisionFDA has grown to support collaborative use cases around genomics, multi-omics, real-world data, and AI and machine learning.
Collaborative regulatory review represents the next adaptation of DNAnexus's Trusted Research Environment capabilities and seeks to help life sciences organizations and global health authorities leverage regulatory and scientific cloud platforms to achieve greater efficiencies on a regional and international scale.
FDA Selects DNAnexus to Power precisionFDA Collaborative
Omics Environment in the Cloud
The partnership enables FDA to enhance precisionFDA capabilities for sponsor-reviewer interaction, add support for multi-omics, and provide a library of analytical, statistical, and machine learning applications, accessible to reviewers and powerful enough for bioinformaticians.